Picture of Fresh2 logo

FREHY — Fresh2 News Story

0.000.00%
us flag iconLast trade - 00:00
FinancialsSpeculativeMicro Cap

Brief: AnPac Says China’S NMPA Approved Starting Of Registration Testing Of AnPac Bio Class III Medical Device

Feb 8 (Reuters) - AnPac Bio-Medical Science Co Ltd  ANPC.O :
    * CHINA’S NMPA APPROVED STARTING OF REGISTRATION TESTING OF
ANPAC
BIO CLASS III MEDICAL DEVICE (FOR LUNG CANCER AUXILIARY
DIAGNOSIS UTILITY)

Source text for Eikon:  ID:nGNX6bttRs 
Further company coverage:  ANPC.O 

 ((Reuters.Briefs@thomsonreuters.com;))

Recent news on Fresh2

See all news